Amgen to invest $600 million in new research and development facility in California 

It is the latest U.S. investment by a drugmaker as President Donald Trump threatens to impose tariffs on pharmaceuticals imported into the U.S.

Leave a Reply

Your email address will not be published. Required fields are marked *